We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
ZeptoMetrix an Antylia scientific company

Download Mobile App




Computer Forecasts Outcome of Breast Cancer

By Biotechdaily staff writers
Posted on 02 Aug 2002
In a preliminary study, a new computer system correctly predicted the outcome of breast cancer in almost 90% of patients. More...
The researchers say the system may someday help save lives by helping specialists determine which patients should have intensive treatment at an early stage. The study findings were reported in the July 27, 2002, issue of New Scientist.

The technique was developed by two scientists, Dr. Gajanan Sherbet and Dr. Raouf Naguib, at Newcastle University (UK), as an extension of image cytometry. They programmed their computer to measure four indicators of cancer aggressiveness: the proportion of cells with extra DNA, the pattern of DNA levels in the whole sample, the number of cells that were dividing, and the shape of the cell nuclei. This information was fed into a neural network and then subjected to fuzzy logic, which weights data to make it fit the patterns as closely as possible.

The scientists then calibrated the system, using tissue samples from 50 breast cancer patients and data about the outcome in each case, such as recurrence of the cancer and the five-year survival rate. Data from another 50 cases were fed into the computer, which was then asked to predict which women would develop tumors in their lymph nodes. The computer did so, with 88% accuracy and gave a similar figure when asked to predict which women would still be alive after five years.

"We believe that this technique has produced more reliable prognostic factor models that those obtained using either the statistical or artificial neural network-based methods,” stated the research team. They also noted that the research suggests that some of the statistical methods currently used may be unreliable.




Related Links:
Newcastle U.

Platinum Member
Xylazine Immunoassay Test
Xylazine ELISA
Verification Panels for Assay Development & QC
Seroconversion Panels
Complement 3 (C3) Test
GPP-100 C3 Kit
Gold Member
ESR Analyzer
miniiSED™
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: QIP-MS could predict and detect myeloma relapse earlier compared to currently used techniques (Photo courtesy of Adobe Stock)

Mass Spectrometry-Based Monitoring Technique to Predict and Identify Early Myeloma Relapse

Myeloma, a type of cancer that affects the bone marrow, is currently incurable, though many patients can live for over 10 years after diagnosis. However, around 1 in 5 individuals with myeloma have a high-risk... Read more

Immunology

view channel
Image: The cancer stem cell test can accurately choose more effective treatments (Photo courtesy of University of Cincinnati)

Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer

Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more

Technology

view channel
Image: Ziyang Wang and Shengxi Huang have developed a tool that enables precise insights into viral proteins and brain disease markers (Photo courtesy of Jeff Fitlow/Rice University)

Light Signature Algorithm to Enable Faster and More Precise Medical Diagnoses

Every material or molecule interacts with light in a unique way, creating a distinct pattern, much like a fingerprint. Optical spectroscopy, which involves shining a laser on a material and observing how... Read more

Industry

view channel
Image: The collaboration aims to leverage Oxford Nanopore\'s sequencing platform and Cepheid\'s GeneXpert system to advance the field of sequencing for infectious diseases (Photo courtesy of Cepheid)

Cepheid and Oxford Nanopore Technologies Partner on Advancing Automated Sequencing-Based Solutions

Cepheid (Sunnyvale, CA, USA), a leading molecular diagnostics company, and Oxford Nanopore Technologies (Oxford, UK), the company behind a new generation of sequencing-based molecular analysis technologies,... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.